Title	Publication Date	Language	Citations
Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development	2012/12/01	English	400
Does correcting myths about the flu vaccine work? An experimental evaluation of the effects of corrective information	2015/01/01	English	372
Strategies intended to address vaccine hesitancy: Review of published reviews	2015/08/01	English	370
TLR-based immune adjuvants	2011/04/01	English	364
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)	2015/08/01	English	364
The test-negative design for estimating influenza vaccine effectiveness	2013/04/01	English	349
Vaccine adjuvants revisited	2007/05/01	English	349
Immune responses to human papillomavirus	2006/03/01	English	344
Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England	2020/11/01	English	344
Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: Insights for understanding the impact of rotavirus vaccination programs	2012/04/01	English	342
Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity	2011/03/16	English	338
Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only	2006/08/14	English	338
Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician's recommendation	2011/01/01	English	332
Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017	2018/06/01	English	327
Factors associated with HPV vaccine uptake in teenage girls: A systematic review	2012/05/01	English	327
Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: Updated recommendations from the World Health Organization Pneumococcal Carriage Working Group	2013/12/01	English	326
The 2009 A (H1N1) influenza virus pandemic: A review	2010/07/01	English	326
Induction of secretory immunity and memory at mucosal surfaces	2007/07/01	English	323
Meningococcal surrogates of protection?serum bactericidal antibody activity	2005/03/18	English	322
Hepatitis A virus seroprevalence by age and world region, 1990 and 2005	2010/09/01	English	321
Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong	2021/02/01	English	321
Influenza vaccination of health care workers in hospitals—A review of studies on attitudes and predictors	2009/06/01	English	319
International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples	2021/04/01	English	317
Survey of the prevalence of immunization non-compliance due to needle fears in children and adults	2012/07/01	English	316
The mechanism of action of MF59 – An innately attractive adjuvant formulation	2012/06/01	English	311
Mapping vaccine hesitancy—Country-specific characteristics of a global phenomenon	2014/11/01	English	308
Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes	2011/02/01	English	304
Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection	2016/04/01	English	303
Advances in saponin-based adjuvants	2009/03/01	English	300
Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey	2020/10/01	English	300